Premium
Influence of Age and Strain on Striatal Dopamine Loss in a Genetic Mouse Model of Lesch‐Nyhan Disease
Author(s) -
Jinnah H. A.,
Jones M. D.,
Wojcik B. E.,
Rothstein J. D.,
Hess E. J.,
Friedmann T.,
Breese G. R.
Publication year - 1999
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.1999.0720225.x
Subject(s) - dopamine , hypoxanthine guanine phosphoribosyltransferase , medicine , endocrinology , basal ganglia , hypoxanthine phosphoribosyltransferase , biology , tyrosine hydroxylase , lesch–nyhan syndrome , genetics , mutant , gene , central nervous system
: Lesch‐Nyhan disease is a neurogenetic disorder caused by deficiency of the purine salvage enzyme hypoxanthine‐guanine phosphoribosyltransferase (HPRT). Affected individuals exhibit a characteristic pattern of neurological and behavioral features attributable in part to dysfunction of basal ganglia dopamine systems. In the current studies, striatal dopamine loss was investigated in five different HPRT‐deficient strains of mice carrying one of two different HPRT gene mutations. Caudoputamen dopamine concentrations were significantly reduced in all five of the strains, with deficits ranging from 50.7 to 61.1%. Mesolimbic dopamine was significantly reduced in only three of the five strains, with a range of 31.6‐38.6%. The reduction of caudoputamen dopamine was age dependent, emerging between 4 and 12 weeks of age. Tyrosine hydroxylase and aromatic amino acid decarboxylase, two enzymes responsible for the synthesis of dopamine, were reduced by 22.4‐37.3 and 22.2‐43.1%, respectively. These results demonstrate that HPRT deficiency is strongly associated with a loss of basal ganglia dopamine. The magnitude of dopamine loss measurable is dependent on the genetic background of the mouse strain used, the basal ganglia sub‐region examined, and the age of the animals at assessment.